Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 5 Oct 23 424B5 Prospectus supplement for primary offering
- 21 Apr 23 424B5 Prospectus supplement for primary offering
- 20 Apr 23 424B5 Prospectus supplement for primary offering
- 10 Feb 23 424B5 Prospectus supplement for primary offering
- 31 Jan 23 EFFECT Notice of effectiveness
- 30 Jan 23 424B4 Prospectus supplement with pricing info
-
20 Jan 23 S-3 Shelf registration
KA similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 of Kineta, Inc. of our report dated March 24, 2022 relating to the financial statements of Yumanity Therapeutics, Inc., which appears in Yumanity Therapeutics, Inc’s Annual Report on Form 10-K for the year ended December 31, 2021. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
January 20, 2023